![Richard M. Lipkin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard M. Lipkin
Directeur/Membre du Conseil chez American Committee for the Weizmann Institute of Science
Postes actifs de Richard M. Lipkin
Sociétés | Poste | Début | Fin |
---|---|---|---|
American Committee for the Weizmann Institute of Science
![]() American Committee for the Weizmann Institute of Science Miscellaneous Commercial ServicesCommercial Services American Committee for the Weizmann Institute of Science operates as a community of visionary people who advance the partnership between science and philanthropy. It partners with individuals, families, foundations, and the business community to develop philanthropic funding for the institute; educates the American public about the institute’s research; and represents the institute’s interests in the U.S. through the events such as galas, parlor meetings, and luncheons; meetings with institute scientists and campaigns to spread the news of research discovery. The company was founded by Chaim Weizmann in November 1944 and is headquartered in New York, NY. | Directeur/Membre du Conseil | - | - |
Epivax Oncology, Inc.
![]() Epivax Oncology, Inc. BiotechnologyHealth Technology Epivax Oncology, Inc. engages in computational-immunology, genomics and vaccine design. It develops mutanome-directed, neo-epitope personalized therapeutic vaccines. The company was founded by Gad Berdugo, Anne De Groot, and Martin William in 2017 and is headquartered in New York, NY. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Richard M. Lipkin
Anciens postes connus de Richard M. Lipkin
Sociétés | Poste | Début | Fin |
---|---|---|---|
NSV II Management Co. LLC
![]() NSV II Management Co. LLC Investment ManagersFinance NSV II Management Co. LLC provides investment management services. It is a private equity and venture capital firm specializing in investing in growth capital, growth and expansion stage, recapitalization, mid stage, late stage, mezzanine, control buyouts, mergers and acquisitions and management buyouts in middle market companies. The company was founded by Michael A. DiPiano and Marc R. Lederman in 1999 and is headquartered in Radnor, PA. | Corporate Officer/Principal | - | 01/01/2006 |
Statistiques
Internationale
Etats-Unis | 4 |
Opérationnelle
Director/Board Member | 2 |
Corporate Officer/Principal | 1 |
Sectorielle
Finance | 2 |
Commercial Services | 2 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 3 |
---|---|
NSV II Management Co. LLC
![]() NSV II Management Co. LLC Investment ManagersFinance NSV II Management Co. LLC provides investment management services. It is a private equity and venture capital firm specializing in investing in growth capital, growth and expansion stage, recapitalization, mid stage, late stage, mezzanine, control buyouts, mergers and acquisitions and management buyouts in middle market companies. The company was founded by Michael A. DiPiano and Marc R. Lederman in 1999 and is headquartered in Radnor, PA. | Finance |
American Committee for the Weizmann Institute of Science
![]() American Committee for the Weizmann Institute of Science Miscellaneous Commercial ServicesCommercial Services American Committee for the Weizmann Institute of Science operates as a community of visionary people who advance the partnership between science and philanthropy. It partners with individuals, families, foundations, and the business community to develop philanthropic funding for the institute; educates the American public about the institute’s research; and represents the institute’s interests in the U.S. through the events such as galas, parlor meetings, and luncheons; meetings with institute scientists and campaigns to spread the news of research discovery. The company was founded by Chaim Weizmann in November 1944 and is headquartered in New York, NY. | Commercial Services |
Epivax Oncology, Inc.
![]() Epivax Oncology, Inc. BiotechnologyHealth Technology Epivax Oncology, Inc. engages in computational-immunology, genomics and vaccine design. It develops mutanome-directed, neo-epitope personalized therapeutic vaccines. The company was founded by Gad Berdugo, Anne De Groot, and Martin William in 2017 and is headquartered in New York, NY. | Health Technology |
- Bourse
- Insiders
- Richard M. Lipkin
- Expérience